cellink

BICO Buys Bioprinting Startup Allegro 3D—8th Acquisition in a Year

BICO (STO: BICO) has purchased another bioprinting startup, adding to its now massive portfolio of 13 acquisitions. This time around, it was rapid-throughput bioprinting company Allegro 3D, a spin-off from…

Featured

Bioprinting’s Trouble in Paradise: BICO Tackles Management Issues After Co-Founder Resigns as CFO

On April 25, 2022, BICO (STO: BICO) co-founder Gusten Danielsson left his post as Chief Financial Officer (CFO) at the biotech corporation. Just hours later, he gave an explosive interview…

3D Printing News Briefs, March 26, 2022: Bioprinting, Microgravity, & More

In today’s 3D Printing News Briefs, Oerlikon and the Technical University of Munich are founding an advanced manufacturing institute together. In bioprinting news, Fluicell just launched a new system, a…

Testicle Tissues Bioprinted for the First Time to Combat Infertility

A team of scientists working at The University of British Columbia (UBC) ’s Vancouver Prostate Centre have pioneered a new method for bioprinting human testicular cells. The discovery could one…

3D Printing Webinar and Event Roundup: March 20, 2022

We’ve got another busy week of webinars and events to share with you in today’s roundup! Topics include metal 3D printing, simulation software, the oil and gas industry’s supply chain,…

Featured

Bioprinting Battle Ends: BICO and Organovo Come to Licensing Agreement

The clash between bioprinting pioneer and powerhouse have come to an end. San Diego, California-based Organovo Holdings, Inc. (Nasdaq: ONVO) and Gothenburg, Sweden-based BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) have…

Featured

How this Medtech Startup Found a Niche Bioprinting Tumor Models

In the battle against a disease that kills roughly 26,000 people each day, the importance of greater speed in drug development is critical. In 2018, an estimated 9.5 million people…

AMS Speaker Spotlight: Analyzing the Market for Smart Bioinks

One of the largest barriers to producing new bioprinting applications is creating and refining the advanced bioinks required for printing human tissue models. For example, consider the use of 3D…

To End Animal Testing, BICO & CCS Push FDA Modernization Act

As the world continues developing alternatives to animal testing like bioprinting, in vitro models of human tissues, and predictive computer models, the demand for live animal testing has become outdated…

Featured

AMS 2022 3D Printing Event: Early Bird Registration Ends January 19th

In less than two months, Additive Manufacturing Strategies, the 3D printing summit co-hosted by 3DPrint.com and SmarTech Analysis, will return as a hybrid event March 1-3, 2022. While last year…

Featured

2022 Predictions: Bioprinting Leaders Weigh in

As 2021 comes to a close, the bioprinting field has a lot of reasons to be optimistic about the future. The bioprinting landscape has evolved rapidly in the last decade,…

Featured

Cellink and Nanoscribe Unveil New Submicron Bioprinter

Building on its strategy of democratizing bioprinting for researchers worldwide, biotech company Cellink teamed up with Nanoscribe, a supplier of high-precision microfabrication systems, to deliver a new submicron bioprinter. Both…

BICO Announces Million-Dollar Contract for 3D Printed Joint Implants

For five years, Nanochon has been developing a 3D printed implantable device and novel nanomaterial to treat cartilage loss and damage in joints as an alternative to knee replacements. Now,…

AMS 2022: Early Bird Rate for NYC 3D Printing Event Expires December 15

Additive Manufacturing Strategies, the foremost 3D printing event in the northeast, is coming to New York City this spring, March 1st through the 3rd. While last year our 3D printing…

AMS 2022 Lines up New Speakers and Sponsors for 3D Printing Event

The Additive Manufacturing Strategies (AMS) summit is scheduled to take place in New York City this coming March 1 to 3, 2022 in a hybrid format: in-person and online, as…

BICO Granted Bioprinting Patents That “Improve Cell Viability and Reproducibility”

Leading biotechnology firm BICO has been issued two patents to help regulate and control temperature during the 3D bioprinting process. According to its inventors, they will allow for higher cell…

3D Printing News Briefs, October 9, 2021: Automation, Bioprinting, & More

We’re starting with new materials in today’s 3D Printing News Briefs, then moving on to automation, bioprinting, and business. B9Creations introduced new resins for 3D printed molds and production parts,…

Featured

Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over

In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…

Nanoscribe’s New Microfabrication 3D Printer Makes Complex Structures for Life Sciences

German company Nanoscribe, a leading developer of high-precision additive manufacturing technologies and part of the BICO group (formerly known as Cellink), launched a new high-precision 3D printer for manufacturing elaborate…

Featured

Sixth Bioprinting Acquisition in One Year from Cellink Parent Company BICO

Pioneering bioprinting firm Cellink, now part of a larger company rebranded as BICO (short for bioconvergence), has already been making quite a name for itself and is preparing to capture…

Featured

Cellink Expands its Bioconvergence Footprint in India

Bioconvergence company Cellink partnered with 3D printing technology supplier Altem Technologies to accelerate the groundwork for life-sciences bioprinting in the Indian market. Local research institutions and hospitals can now contact…

Cellink Acquires Revolutionary Microscopy Firm for $110M

Bioprinting rocket Cellink unveiled a $110 million deal to acquire disruptive microscope manufacturer Discover Echo. The move is expected to generate roughly $20 million in revenue in 2021 and is…

NASA Will Announce Winners of Challenge to Engineer Human Tissue

During a live event on June 9, 2021, NASA will announce the first- and second-place winners of the Vascular Tissue Challenge, a prize competition to grow and sustain functioning tissue…

Featured

Cellink Acquires Two Startups for $50M, Grows Bioconvergence Offerings

Set in revolutionizing the bioconvergence healthcare segment, Swedish-American company Cellink (CLNK-B.ST) has acquired two new startups to expand its technology offerings: Germany-based Nanoscribe and U.S.-based Visikol. The company said the…